Bokemeyer B - Search Results

1

Real-world effectiveness of vedolizumab compared to anti-TNF agents in biologic-naïve patients with ulcerative colitis: A two-year propensity-score-adjusted analysis from the prospective, observational VEDO_IBD -study.

Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Efken P, Mohl W, Krause T, Hoffstadt M, Ehehalt R, Trentmann L, Schweitzer A, Jessen P, Hartmann P, Schreiber S. Bokemeyer B, et al. Aliment Pharmacol Ther. 2023 Aug;58(4):429-442. doi: 10.1111/apt.17616. Epub 2023 Jun 15. Aliment Pharmacol Ther. 2023. PMID: 37322825

2

[Clinical practice guideline on diagnosis and treatment of Crohn's disease - summary for the general practitioner].

Preiss JC, Bokemeyer B, Siegmund B, Stange EF, Zeitz M, Hoffmann JC; German Gastroenterologic Society and the Competence Network IBD. Preiss JC, et al. Among authors: bokemeyer b. Med Klin (Munich). 2009 Mar 15;104(3):237-43. doi: 10.1007/s00063-009-1037-3. Med Klin (Munich). 2009. PMID: 19337714 German.

3

[Pseudo-esophagitis in antacid abuse].

Bokemeyer B, Vogt U, Stadler R, Wagner S. Bokemeyer B, et al. Leber Magen Darm. 1996 Nov;26(6):320, 323-4. Leber Magen Darm. 1996. PMID: 9082114 German.

4

Addressing unmet needs in inflammatory bowel disease.

Bokemeyer B. Bokemeyer B. Drug Discov Today. 2015 Sep;20(9):1037-9. doi: 10.1016/j.drudis.2015.07.005. Epub 2015 Jul 29. Drug Discov Today. 2015. PMID: 26232319 No abstract available.

5

Langbrandtner J, Steimann G, Reichel C, Bokemeyer B, Hüppe A. Langbrandtner J, et al. Among authors: bokemeyer b. Rehabilitation (Stuttg). 2021 Feb;60(1):29-36. doi: 10.1055/a-1248-5703. Epub 2020 Nov 5. Rehabilitation (Stuttg). 2021. PMID: 33152779 German.

6

Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency.

Bokemeyer B, Krummenerl A, Maaser C, Howaldt S, Mroß M, Mallard N. Bokemeyer B, et al. Eur J Drug Metab Pharmacokinet. 2017 Apr;42(2):229-238. doi: 10.1007/s13318-016-0334-5. Eur J Drug Metab Pharmacokinet. 2017. PMID: 27101422 Clinical Trial.

7

Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.

Herrlinger KR, Witthoeft T, Raedler A, Bokemeyer B, Krummenerl T, Schulzke JD, Boerner N, Kueppers B, Emmrich J, Mescheder A, Schwertschlag U, Shapiro M, Stange EF. Herrlinger KR, et al. Among authors: bokemeyer b. Am J Gastroenterol. 2006 Apr;101(4):793-7. doi: 10.1111/j.1572-0241.2005.00356.x. Am J Gastroenterol. 2006. PMID: 16635225 Clinical Trial.

8

[Combined therapy with azithromycin and omeprazole for the eradication of Helicobacter pylori].

Bokemeyer B. Bokemeyer B. Dtsch Med Wochenschr. 1995 Sep 29;120(39):1339. Dtsch Med Wochenschr. 1995. PMID: 7555645 German. No abstract available.

9

[Inflammatory Bowel Disease - Challenges in the Workplace and Support for Coping with Disease].

Langbrandtner J, Steimann G, Reichel C, Bokemeyer B, Hüppe A. Langbrandtner J, et al. Among authors: bokemeyer b. Rehabilitation (Stuttg). 2022 Apr;61(2):97-106. doi: 10.1055/a-1581-6497. Epub 2021 Sep 20. Rehabilitation (Stuttg). 2022. PMID: 34544161 German.

10

A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease.

Teml A, Schwab M, Hommes DW, Almer S, Lukas M, Feichtenschlager T, Florin T, Seiderer J, Petritsch W, Bokemeyer B, Kreisel W, Herrlinger KR, Knoflach P, Bonaz B, Klugmann T, Herfarth H, Pedarnig N, Reinisch W. Teml A, et al. Among authors: bokemeyer b. Wien Klin Wochenschr. 2007;119(17-18):519-26. doi: 10.1007/s00508-007-0841-0. Wien Klin Wochenschr. 2007. PMID: 17943403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page